You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 9,238,657

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,238,657 protect, and when does it expire?

Patent 9,238,657 protects FETROJA and is included in one NDA.

This patent has forty-six patent family members in thirty-seven countries.

Summary for Patent: 9,238,657

Title:	Cephalosporin having catechol group
Abstract:	The present disclosure describes Cephem compounds of the formula: ##STR00001## wherein, X is N, CH or C--Cl; T is S or the like; A and G are lower alkylene or the like; B is a single bond or the like; D is optionally present, and when present is, --NR.sup.7--, --CO--, --CO--NR.sup.7--, --NR.sup.7--CO--, --NR.sup.7--CO--NR.sup.7--, or the like; F is optionally present, and when present is or phenylene; R.sup.3 and R.sup.4 are --OR.sup.8; R.sup.5 and R.sup.6 each is independently hydrogen, halogen, nitrile, or --OR.sup.8; or an ester at the carboxyl at the 7-position side chain or at the 4-position, a compound protected at the amino on the ring in the 7-side chain, a pharmaceutically acceptable salt, or a solvate thereof, which have a wide antimicrobial spectrum and have potent antimicrobial activity against beta-lactamase producing Gram negative bacteria.
Inventor(s):	Nishitani; Yasuhiro (Osaka, JP), Yamawaki; Kenji (Osaka, JP), Takeoka; Yusuke (Sapporo, JP), Sugimoto; Hideki (Osaka, JP), Hisakawa; Shinya (Osaka, JP), Aoki; Toshiaki (Osaka, JP)
Assignee:	SHIONOGI & CO., LTD. (Osaka, JP)
Application Number:	13/063,878
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Drugs Protected by US Patent 9,238,657

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y		METHOD OF TREATING BACTERIAL INFECTIONS	⤷ Sign Up
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y		METHOD OF TREATING COMPLICATED URINARY TRACT INFECTIONS (CUTI), INCLUDING PYELONEPHRITIS, COMPRISING ADMINISTERING CEFIDEROCOL SULFATE TOSYLATE	⤷ Sign Up
Shionogi Inc	FETROJA	cefiderocol sulfate tosylate	POWDER;INTRAVENOUS	209445-001	Nov 14, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y	Y		METHOD OF TREATING HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA (HABP/VABP) COMPRISING ADMINISTERING CEFIDEROCOL SULFATE TOSYLATE	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,238,657

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2008-280828	Oct 31, 2008

PCT Information
PCT Filed	October 27, 2009	PCT Application Number:	PCT/JP2009/068400
PCT Publication Date:	May 06, 2010	PCT Publication Number:	WO2010/050468

International Family Members for US Patent 9,238,657

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2960244	⤷ Sign Up	301067	Netherlands	⤷ Sign Up
European Patent Office	2960244	⤷ Sign Up	CA 2020 00049	Denmark	⤷ Sign Up
European Patent Office	2960244	⤷ Sign Up	LUC00179	Luxembourg	⤷ Sign Up
European Patent Office	2960244	⤷ Sign Up	PA2020530	Lithuania	⤷ Sign Up
European Patent Office	2960244	⤷ Sign Up	122020000060	Germany	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.